v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 8,836 $ 4,235
Accounts receivable 268 30
Research and development tax credit receivable 610 1,121
Prepaid expenses and other current assets 811 1,056
Total current assets 10,525 6,442
Property, plant and equipment, net 455 602
Right-of-use assets, net 285 475
Other assets, non-current 7 6
Total assets 11,272 7,525
Current liabilities    
Accounts payable and accrued expenses 1,178 931
Lease liabilities, current 230 206
Income tax payable   22
Other current liabilities 360 244
Total current liabilities 1,768 1,403
Lease liabilities, non-current 19 239
Warrant liability 1,372  
Total liabilities 3,159 1,642
Commitments and contingencies (Note 7)
Stockholders' equity:    
Preferred stock, par value $0.0001 per share, 10,000,000 shares authorized, 13,765 and zero shares issued and outstanding, at December 31, 2023 and December 31, 2022, respectively
Common stock, par value $0.0001 per share, 300,000,000 shares authorized, 889,668 and 771,054 shares issued and outstanding, at December 31, 2023 and December 31, 2022, respectively
Additional paid-in capital 104,757 92,933
Accumulated other comprehensive loss (1,578) (483)
Accumulated deficit (95,066) (86,567)
Total stockholders' equity 8,113 5,883
Total liabilities and stockholders' equity $ 11,272 $ 7,525

Source

HTML PDF
ZIP